Señales en vivo de ARIX.L | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 feb 2024 @ 12:15):

Stats
Volumen de hoy	13.86M
Volumen promedio	462 154
Capitalización de mercado	183.73M
EPS	£0 ( 2024-04-22 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	12.91
ATR14	£2.89 (2.03%)

Volumen Correlación

Largo: 0.24 (neutral)

Corto: -0.87 (strong negative)

Signal:(69.448) Neutral

Arix Bioscience PLC Correlación

10 Correlaciones Más Positivas
JUSC.L	0.918
FLO.L	0.886
ADVT.L	0.871
EPWN.L	0.863
ALU.L	0.842
ATS.L	0.836
AHT.L	0.832
MTR.L	0.831
SLI.L	0.829
TBCG.L	0.828

10 Correlaciones Más Negativas
TRS3.L	-0.842
MDBG.L	-0.819
PHPM.L	-0.815
DDBG.L	-0.806

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arix Bioscience PLC Correlación - Moneda/Commodity

0.42
( neutral )

0.84
( strong )

0.39
( neutral )

0.66
( moderate )

-0.86
( strong negative )

-0.39
( neutral )

Arix Bioscience PLC Finanzas

Annual	2022
Ingresos:	£112 000
Beneficio Bruto:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2022
Ingresos:	£112 000
Beneficio Bruto:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2021
Ingresos:	£340 000
Beneficio Bruto:	£0.00 (0.00 %)
EPS:	£-0.582

FY	2020
Ingresos:	£477 000
Beneficio Bruto:	£0.00 (0.00 %)
EPS:	£0.968

Financial Reports:

No articles found.

Arix Bioscience PLC

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.